Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
19.02
-0.34 (-1.76%)
At close: Dec 30, 2025, 4:00 PM EST
19.02
0.00 (0.00%)
After-hours: Dec 30, 2025, 5:56 PM EST
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.93 billion as of December 30, 2025. Its market cap has increased by 27.73% in one year.
Market Cap
1.93B
Enterprise Value
1.56B
1-Year Change
27.73%
Ranking
Category
Stock Price
$19.02
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.93B, an increase of 173.83%. That is a compound annual growth rate of 20.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 1.96B | 47.05% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |